Ocio, E. M., Efebera, Y. A., Hájek, R., Straub, J., Maisnar, V., Eveillard, J.-R., Karlin, L., Mateos, M.-V., Oriol, A., Ribrag, V., Richardson, P. G., Norin, S., Obermüller, J., Bakker, N. A. and Pour, L. (2024) “ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study”, Haematologica. Pavia, Italy, 109(3), pp. 867-876. doi: 10.3324/haematol.2023.283490.